Dr. Jayasree Iyer, Executive Director of the Access to Medicine Foundation (ATMF), sits down with The Max Foundation and answers seven questions about the Access to Medicine Index, emerging trends in treatment access, and the role of collaborative access initiatives in treating chronic diseases.
The Max Foundation leads the way in developing systems to ensure adverse event reports are shared promptly with local health authorities through prescribers, and with drug manufacturers alike.
At The Max Foundation, I am reminded every day of the critical role our physician partners play in saving the lives of thousands of cancer patients worldwide. Dr. Kazakbaeva from Uzbekistan is a shining example of a physician who goes above and beyond for people facing cancer.
October 19th is Max’s Day. We honor the day because it marks Max’s birthday. At the very same time, we honor all the people who have been helped in his name.
The Union for International Cancer Control (UICC) has been hosting the World Cancer Congress each year since 1933. This year it was held in Malaysia – the first time in South East Asia.
David Verga, Communications Manager for The Max Foundation, reflects on his recent experiences interviewing patient leaders from across Africa at the recent Max Global Experience: Uganda.
Rising Sun 2018 has more than 60 participants from 18 countries, consisting of patient leaders, physicians, pharma representatives, advocates, caregivers, and volunteers. Growing beyond our original scope of capacity building, this year we have brought Rising Sun to another level: Access to Treatment is Access to Life – Everyone Has a Role!
The story of Malick, a 64-year-old father and cancer survivor from Senegal, whose life has been changed by gaining access to treatment through Max Access Solutions.
The story of Kankou, a 37-year-old mother and cancer survivor from Senegal, who makes a recurring, 450km, “last mile” journey to access cancer medication donated through The Max Foundation.
Read the story of Alassane, a leukemia patient from Senegal now receiving a lifesaving second-line medication through our Max Access Solutions, and the incredible 700km "last mile" journey he must make to access the treatment.
For many people facing cancer, the “last mile” in treatment access is a long, expensive, and recurring journey. But in Constantine’s case, even this journey may not be enough. The distance itself is not so far but the journey is long – 8 hours by public buses and transport. Constantine, like so many others around the world, has a rare form of leukemia called CML (chronic myeloid leukemia).
Launched in 2015, Chai for Cancer USA raises funds to provide treatment access for patients in India. The campaign’s inspiration and namesake come from our own Region Head for South...